Thermo Historical Income Statement

TMO Stock

USD 521.66 8.68 1.69%

Historical analysis of Thermo Fisher income statement accounts such as Operating Income of 7.2 B, Ebit of 7.2 B, EBITDA of 7.2 B or Cost Of Revenue of 26.6 B can show how well Thermo Fisher Scientific performed in making a profits. Evaluating Thermo Fisher income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Thermo Fisher's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Thermo Fisher Scientific latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Thermo Fisher Scientific is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Thermo Income Statement Analysis

Thermo Fisher Scientific Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Thermo Fisher shareholders. The income statement also shows Thermo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Thermo Fisher Income Statement Chart

At this time, Thermo Fisher's EBITDA is very stable compared to the past year. As of the 29th of November 2024, Cost Of Revenue is likely to grow to about 26.6 B, though Total Other Income Expense Net is likely to grow to (533 M).

Total Revenue Gross Profit Other Operating Expenses Operating Income Net Income Discontinued Operations

Total Revenue

Total revenue comprises all receipts Thermo Fisher Scientific generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Thermo Fisher Scientific minus its cost of goods sold. It is profit before Thermo Fisher operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Thermo Fisher Scientific. It is also known as Thermo Fisher overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Thermo Fisher Scientific operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Thermo Fisher Scientific is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Thermo Fisher Scientific financial statement analysis. It represents the amount of money remaining after all of Thermo Fisher Scientific operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most accounts from Thermo Fisher's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Thermo Fisher Scientific current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2021	2022	2023	2024 (projected)
Total Revenue	39.2B	44.9B	42.9B	45.0B
Depreciation And Amortization	2.6B	3.4B	3.4B	3.6B

Total Revenue Depreciation And Amortization

Thermo Fisher income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Expense	Selling General Administrative	Research Development	Minority Interest	Net Income From Continuing Ops	Non Recurring	Discontinued Operations	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Non Operating Income Net Other
Depreciation And Amortization		0.97	0.94	0.98	0.85	0.85	0.8	0.97	0.99	0.86	-0.57	0.88	0.19	0.9	0.98	0.97	0.22	0.76	0.14	-0.18	0.67	0.46	-0.75	0.83	-0.42
Total Revenue	0.97		0.98	0.99	0.94	0.93	0.87	0.99	0.98	0.94	-0.7	0.95	0.31	0.84	0.95	0.98	0.21	0.86	0.2	-0.16	0.79	0.47	-0.72	0.87	-0.56
Gross Profit	0.94	0.98		0.96	0.98	0.97	0.94	0.95	0.97	0.97	-0.75	0.98	0.46	0.76	0.93	0.99	0.1	0.91	0.19	-0.16	0.87	0.35	-0.7	0.8	-0.65
Other Operating Expenses	0.98	0.99	0.96		0.9	0.89	0.82	1.0	0.98	0.9	-0.65	0.92	0.22	0.88	0.96	0.96	0.24	0.81	0.17	-0.17	0.72	0.5	-0.73	0.88	-0.49
Operating Income	0.85	0.94	0.98	0.9		1.0	0.96	0.88	0.9	1.0	-0.81	1.0	0.58	0.65	0.84	0.94	0.07	0.96	0.2	-0.1	0.94	0.31	-0.63	0.76	-0.76
Ebit	0.85	0.93	0.97	0.89	1.0		0.97	0.88	0.9	1.0	-0.84	0.99	0.59	0.63	0.83	0.94	0.05	0.96	0.25	-0.11	0.95	0.29	-0.63	0.76	-0.77
Ebitda	0.8	0.87	0.94	0.82	0.96	0.97		0.8	0.86	0.96	-0.78	0.94	0.72	0.5	0.77	0.91	-0.19	0.95	0.18	-0.13	0.95	0.08	-0.52	0.66	-0.73
Cost Of Revenue	0.97	0.99	0.95	1.0	0.88	0.88	0.8		0.96	0.89	-0.65	0.91	0.19	0.89	0.94	0.94	0.28	0.79	0.19	-0.15	0.7	0.54	-0.73	0.91	-0.48
Total Operating Expenses	0.99	0.98	0.97	0.98	0.9	0.9	0.86	0.96		0.9	-0.63	0.92	0.31	0.85	0.98	0.98	0.13	0.82	0.11	-0.2	0.75	0.39	-0.72	0.79	-0.51
Income Before Tax	0.86	0.94	0.97	0.9	1.0	1.0	0.96	0.89	0.9		-0.81	1.0	0.57	0.65	0.84	0.94	0.08	0.96	0.21	-0.1	0.94	0.34	-0.63	0.78	-0.74
Total Other Income Expense Net	-0.57	-0.7	-0.75	-0.65	-0.81	-0.84	-0.78	-0.65	-0.63	-0.81		-0.81	-0.49	-0.41	-0.57	-0.69	-0.1	-0.8	-0.49	0.1	-0.83	-0.16	0.47	-0.58	0.78
Net Income	0.88	0.95	0.98	0.92	1.0	0.99	0.94	0.91	0.92	1.0	-0.81		0.52	0.69	0.86	0.95	0.12	0.95	0.22	-0.09	0.92	0.38	-0.64	0.8	-0.72
Income Tax Expense	0.19	0.31	0.46	0.22	0.58	0.59	0.72	0.19	0.31	0.57	-0.49	0.52		-0.19	0.18	0.41	-0.62	0.66	-0.01	0.04	0.77	-0.42	-0.04	0.1	-0.64
Interest Expense	0.9	0.84	0.76	0.88	0.65	0.63	0.5	0.89	0.85	0.65	-0.41	0.69	-0.19		0.91	0.8	0.57	0.52	0.07	-0.14	0.42	0.68	-0.82	0.76	-0.22
Selling General Administrative	0.98	0.95	0.93	0.96	0.84	0.83	0.77	0.94	0.98	0.84	-0.57	0.86	0.18	0.91		0.95	0.24	0.73	0.08	-0.21	0.67	0.48	-0.78	0.74	-0.42
Research Development	0.97	0.98	0.99	0.96	0.94	0.94	0.91	0.94	0.98	0.94	-0.69	0.95	0.41	0.8	0.95		0.11	0.88	0.13	-0.14	0.83	0.33	-0.73	0.79	-0.57
Minority Interest	0.22	0.21	0.1	0.24	0.07	0.05	-0.19	0.28	0.13	0.08	-0.1	0.12	-0.62	0.57	0.24	0.11		-0.03	0.15	0.13	-0.07	0.76	-0.51	0.35	0.0
Net Income From Continuing Ops	0.76	0.86	0.91	0.81	0.96	0.96	0.95	0.79	0.82	0.96	-0.8	0.95	0.66	0.52	0.73	0.88	-0.03		0.2	-0.07	0.93	0.22	-0.51	0.76	-0.75
Non Recurring	0.14	0.2	0.19	0.17	0.2	0.25	0.18	0.19	0.11	0.21	-0.49	0.22	-0.01	0.07	0.08	0.13	0.15	0.2		-0.08	0.22	0.07	-0.26	0.23	-0.29
Discontinued Operations	-0.18	-0.16	-0.16	-0.17	-0.1	-0.11	-0.13	-0.15	-0.2	-0.1	0.1	-0.09	0.04	-0.14	-0.21	-0.14	0.13	-0.07	-0.08		-0.03	-0.03	0.05	-0.04	0.02
Tax Provision	0.67	0.79	0.87	0.72	0.94	0.95	0.95	0.7	0.75	0.94	-0.83	0.92	0.77	0.42	0.67	0.83	-0.07	0.93	0.22	-0.03		0.11	-0.56	0.58	-0.8
Interest Income	0.46	0.47	0.35	0.5	0.31	0.29	0.08	0.54	0.39	0.34	-0.16	0.38	-0.42	0.68	0.48	0.33	0.76	0.22	0.07	-0.03	0.11		-0.47	0.57	0.05
Net Interest Income	-0.75	-0.72	-0.7	-0.73	-0.63	-0.63	-0.52	-0.73	-0.72	-0.63	0.47	-0.64	-0.04	-0.82	-0.78	-0.73	-0.51	-0.51	-0.26	0.05	-0.56	-0.47		-0.57	0.34
Reconciled Depreciation	0.83	0.87	0.8	0.88	0.76	0.76	0.66	0.91	0.79	0.78	-0.58	0.8	0.1	0.76	0.74	0.79	0.35	0.76	0.23	-0.04	0.58	0.57	-0.57		-0.41
Non Operating Income Net Other	-0.42	-0.56	-0.65	-0.49	-0.76	-0.77	-0.73	-0.48	-0.51	-0.74	0.78	-0.72	-0.64	-0.22	-0.42	-0.57	0.0	-0.75	-0.29	0.02	-0.8	0.05	0.34	-0.41

Click cells to compare fundamentals

Thermo Fisher Account Relationship Matchups

Thermo Fisher income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	2.0B	2.3B	2.6B	3.4B	3.4B	3.6B
Total Revenue	25.5B	32.2B	39.2B	44.9B	42.9B	45.0B
Gross Profit	11.8B	16.5B	20.2B	19.5B	17.6B	18.4B
Other Operating Expenses	21.4B	24.3B	29.0B	36.4B	36.0B	37.8B
Operating Income	4.6B	7.8B	10.0B	8.4B	6.9B	7.2B
Ebit	4.6B	7.9B	10.4B	8.6B	6.9B	7.2B
Ebitda	6.6B	10.2B	13.0B	11.9B	6.9B	7.2B
Cost Of Revenue	13.7B	15.7B	19.0B	25.4B	25.3B	26.6B
Total Operating Expenses	7.6B	8.6B	10.0B	11.0B	10.7B	11.2B
Income Before Tax	4.1B	7.2B	8.8B	7.8B	6.3B	6.6B
Total Other Income Expense Net	(524M)	(567M)	(1.2B)	(558M)	(561M)	(533.0M)
Net Income	3.7B	6.4B	7.7B	7.0B	6.0B	6.3B
Income Tax Expense	374M	850M	1.1B	703M	(284M)	(269.8M)
Interest Expense	676M	553M	536M	726M	1.4B	1.4B
Selling General Administrative	6.1B	6.9B	6.8B	7.1B	8.6B	9.0B
Research Development	1.0B	1.2B	1.4B	1.5B	1.3B	1.4B
Net Income Applicable To Common Shares	3.7B	6.4B	7.7B	7.0B	8.0B	8.4B
Net Income From Continuing Ops	3.7B	6.4B	7.7B	7.0B	5.9B	3.5B
Non Recurring	(413M)	99M	197M	114M	131.1M	137.7M
Tax Provision	324M	374M	850M	1.1B	703M	469.3M
Interest Income	224M	488M	43M	272M	720M	756M
Net Interest Income	(452M)	(488M)	(493M)	(454M)	(534M)	(560.7M)
Reconciled Depreciation	2.3B	2.3B	2.6B	3.4B	3.4B	2.9B

Pair Trading with Thermo Fisher

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thermo Fisher position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thermo Fisher will appreciate offsetting losses from the drop in the long position's value.

Moving together with Thermo Stock

0.74	A	Agilent Technologies	Pair Corr
0.92	ME	23Andme Holding	Pair Corr
0.8	VALN	Valneva SE ADR	Pair Corr

Moving against Thermo Stock

0.79	VCYT	Veracyte	Pair Corr
0.77	DRUG	Bright Minds Biosciences	Pair Corr
0.69	VERA	Vera Therapeutics	Pair Corr
0.67	VCEL	Vericel Corp Ord	Pair Corr
0.62	VANI	Vivani Medical	Pair Corr

The ability to find closely correlated positions to Thermo Fisher could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thermo Fisher when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thermo Fisher - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thermo Fisher Scientific to buy it.

The correlation of Thermo Fisher is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thermo Fisher moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thermo Fisher Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Thermo Fisher can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:

How To Invest In Thermo

Details

Is Thermo Stock a good investment?

Details

What is Thermo Fisher's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.04)

Dividend Share

1.52

Earnings Share

15.96

Revenue Per Share

110.627

Quarterly Revenue Growth

0.002

The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Thermo Historical Income Statement

About Thermo Income Statement Analysis

Thermo Fisher Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Net Income

Thermo Fisher income statement Correlations

Thermo Fisher Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thermo Fisher income statement Accounts

Pair Trading with Thermo Fisher

Moving together with Thermo Stock

Moving against Thermo Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax

Total Other Income Expense Net	- 0.84	Ebit
Tax Provision	- 0.83	Total Other Income Expense Net
Net Interest Income	- 0.82	Interest Expense
Net Income	- 0.81	Total Other Income Expense Net
Total Other Income Expense Net	- 0.81	Income Before Tax
Total Other Income Expense Net	- 0.81	Operating Income